The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...
Newsable Asianet News on MSN9h
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known ...
Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics.
A Visit from St. Nicholas Rodgers open to pay cut but unsure about playing next season Asking Eric Today’s horoscope ...
For almost all of the crews in this year's Sydney to Hobart yacht race, the 628-nautical mile bluewater classic is their "grand final" — but for Annette Hesselmans and her daughter, Sophie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback